Shuku Sato1, Eri Tanaka2, Yotaro Tamai3. Show Affiliations » 1. Division of Hematology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-0072, Japan. ocukuhs719@gmail.com. 2. Division of Internal Medicine, Hayama Heart Center, Hayama, Kanagawa, Japan. 3. Division of Hematology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-0072, Japan.
Abstract
Entities: Chemical Disease
Mesh: See more » AgedAntineoplastic Combined Chemotherapy Protocols/administration & dosageCarboplatin/administration & dosageCyclophosphamide/administration & dosageDendritic Cells/metabolismDendritic Cells/pathologyDexamethasone/administration & dosageDoxorubicin/administration & dosageEtoposide/administration & dosageFatal OutcomeHematologic Neoplasms/diagnosisHematologic Neoplasms/drug therapyHematologic Neoplasms/metabolismHematologic Neoplasms/pathologyHumansIfosfamide/administration & dosageMalePrednisone/administration & dosageSkin Neoplasms/diagnosisSkin Neoplasms/drug therapySkin Neoplasms/metabolismSkin Neoplasms/pathologyVincristine/administration & dosage
Substances: See more » VincristineEtoposideDexamethasoneDoxorubicinCyclophosphamideCarboplatinIfosfamidePrednisone
Year: 2019 PMID: 30652209 DOI: 10.1007/s00277-019-03611-3
Source DB: PubMed Journal: Ann Hematol ISSN: 0939-5555 Impact factor: 3.673